This inventor holds 1 USPTO granted patent. Top assignee: The United States of America as Represented by the Department of Health. Active years: 1990.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1990
Title: The Innovative Contributions of Irene Peres-Schael
Introduction
Irene Peres-Schael is a notable inventor based in San Jose, Venezuela. She has made significant contributions to the field of vaccine development, particularly in the fight against rotavirus diseases. Her work has the potential to impact public health positively.
Latest Patents
Irene holds a patent for a vaccine against rotavirus diseases and the method of preparing it. This innovative method describes a new approach for producing live, attenuated rotavirus strains suitable for vaccine preparation. It demonstrates that a naturally attenuated rotavirus, recovered from newborns or individuals who have undergone asymptomatic infection, can be utilized for immunization. Additionally, it shows that a virulent rotavirus can be converted into an attenuated strain by substituting the conserved fourth rotavirus gene segments of a naturally attenuated rotavirus into the genome of the virulent strain. This patent highlights her commitment to advancing medical science.
Career Highlights
Irene Peres-Schael has worked with the United States of America as represented by the Department of Health. Her career is marked by her dedication to research and innovation in the field of virology and vaccine development.
Collaborations
Throughout her career, Irene has collaborated with esteemed colleagues such as Robert M. Chanock and Albert Z. Kapikian. These collaborations have further enriched her research and contributed to the advancement of vaccine technology.
Conclusion
Irene Peres-Schael's work in developing a vaccine against rotavirus diseases exemplifies her innovative spirit and dedication to improving public health. Her contributions are invaluable in the ongoing fight against infectious diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
